Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Sakaida

Showing results (121-130 of 332) with videos related to

Pageof 34
Sort By:
The Journal of International Medical Research|May 21, 2013
Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedemaIsao Sakaida, Satoyoshi Yamashita, Tomoo Kobayashi, et al.
Gastroenterology Research and Practice|May 28, 2013
Utility of computed tomographic enteroclysis/enterography for the assessment of mucosal healing in Crohn's diseaseShinichi Hashimoto, Kensaku Shimizu, Hiroaki Shibata, et al.
American Journal of Clinical Oncology|October 11, 2008
Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinomaRyu Shiraishi, Takahiro Yamasaki, Issei Saeki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 5, 2013
Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trialIsao Sakaida, Seiji Kawazoe, Kozo Kajimura, et al.
Journal of Gastroenterology and Hepatology|October 30, 2018
Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascitesTakuya Iwamoto, Masaki Maeda, Issei Saeki, et al.
Clinical and Translational Gastroenterology|February 7, 2014
Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7Yoshihiro Onishi, Takafumi Wakita, Shinichi Fukuhara, et al.
Journal of Gastroenterology and Hepatology|January 5, 2007
Relationship between molecular markers and endoscopic findings in laterally spreading tumorsShinichi Hashimoto, Shingo Higaki, Ayaka Amano, et al.
Journal of Gastrointestinal Cancer|September 4, 2013
Efficacy of endoscopic submucosal dissection for cancer of the operated stomachJunichi Nishimura, Jun Nishikawa, Kouichi Hamabe, et al.
Stem Cells (Dayton, Ohio)|March 27, 2018
Analysis of Metabolomic Changes in Mesenchymal Stem Cells on Treatment with Desferrioxamine as a Hypoxia Mimetic Compared with Hypoxic ConditionsKoichi Fujisawa, Taro Takami, Sae Okada, et al.
Journal of Clinical Biochemistry and Nutrition|May 30, 2019
NUPR1 acts as a pro-survival factor in human bone marrow-derived mesenchymal stem cells and is induced by the hypoxia mimetic reagent deferoxamineKazuhito Matsunaga, Koichi Fujisawa, Taro Takami, et al.
Pageof 34

Showing results (121-130 of 332) with videos related to

Sort By:
Pageof 34
The Journal of International Medical Research|May 21, 2013
Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedemaIsao Sakaida, Satoyoshi Yamashita, Tomoo Kobayashi, et al.
Gastroenterology Research and Practice|May 28, 2013
Utility of computed tomographic enteroclysis/enterography for the assessment of mucosal healing in Crohn's diseaseShinichi Hashimoto, Kensaku Shimizu, Hiroaki Shibata, et al.
American Journal of Clinical Oncology|October 11, 2008
Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinomaRyu Shiraishi, Takahiro Yamasaki, Issei Saeki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 5, 2013
Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trialIsao Sakaida, Seiji Kawazoe, Kozo Kajimura, et al.
Journal of Gastroenterology and Hepatology|October 30, 2018
Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascitesTakuya Iwamoto, Masaki Maeda, Issei Saeki, et al.
Clinical and Translational Gastroenterology|February 7, 2014
Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7Yoshihiro Onishi, Takafumi Wakita, Shinichi Fukuhara, et al.
Journal of Gastroenterology and Hepatology|January 5, 2007
Relationship between molecular markers and endoscopic findings in laterally spreading tumorsShinichi Hashimoto, Shingo Higaki, Ayaka Amano, et al.
Journal of Gastrointestinal Cancer|September 4, 2013
Efficacy of endoscopic submucosal dissection for cancer of the operated stomachJunichi Nishimura, Jun Nishikawa, Kouichi Hamabe, et al.
Stem Cells (Dayton, Ohio)|March 27, 2018
Analysis of Metabolomic Changes in Mesenchymal Stem Cells on Treatment with Desferrioxamine as a Hypoxia Mimetic Compared with Hypoxic ConditionsKoichi Fujisawa, Taro Takami, Sae Okada, et al.
Journal of Clinical Biochemistry and Nutrition|May 30, 2019
NUPR1 acts as a pro-survival factor in human bone marrow-derived mesenchymal stem cells and is induced by the hypoxia mimetic reagent deferoxamineKazuhito Matsunaga, Koichi Fujisawa, Taro Takami, et al.
Pageof 34